Common questions
Clear answers to the questions left over.
An online visit, a medicine’s approval and a sport rule each need their own answer. Your clinician is the person caring for you: a doctor or another health professional.
Approval, supply and the withdrawn request
What does approval mean here?
FDA approval tells you that the US medicine agency has reviewed that product for the use being approved.
As of September 2026, BPC-157 had no such US approval for any use. [A]
FDA also reported finding no approved medicine containing it in any country.
Does a clinic’s licence make BPC-157 legal to supply?
No. As of September 2026, a clinic’s licence did not give BPC-157 FDA approval or allow a pharmacy to ignore the ingredient rules.
To compound means to make or mix a medicine for a patient.
As of September 2026, compounded medicines were not FDA-approved, even when made by a licensed pharmacy. [B]
HHS would stand back from enforcing the rule against state-licensed pharmacies and licensed doctors preparing BPC-157 for one patient’s prescription, if they meet the requirements in its October 30, 2026 draft.
Ask which rule allows the exact product being offered. Ask the pharmacist to explain it in writing.
Did a withdrawn request change the rules?
When checked on September 28, 2026, FDA’s page showed that the groups requesting BPC-157’s use had taken back their requests. April 22, 2026 was the page’s update date, not a date given for the withdrawal. [C]
Taking a request back does not grant approval. As of September 2026, it did not allow pharmacies to make BPC-157 from raw ingredients for individual patients.
Is an online form enough for a visit?
State rules differ, as of September 2026; a form is not automatically ruled out.
The medical-board federation’s guidance calls for enough information for proper care and the ability to ask further questions. [D]
Ask how the assessment continues when your concern does not fit the form.
Questions about use and the next step
Does taking BPC-157 by mouth answer the unknowns?
As of September 2026, FDA had too little human information to describe BPC-157’s safety with confidence. [A]
FDA judged a reaction by the body’s germ-fighting system to be less likely with swallowing than with injections. It still raised concerns about unwanted substances in products taken by mouth.
This was FDA’s assessment of possible risks, not a measured rate of reactions. Taking it by mouth does not establish its safety.
What if I compete in sport?
The World Anti-Doping Agency’s current list, as of September 2026, named BPC-157 as prohibited both in competition and outside it. [E]
Its published replacement takes effect on January 1, 2027, and also names BPC-157. [F]
Ask the body that governs your sport about its rules before considering care. A medical conversation does not replace that check.
What if the clinician declines the request?
Ask why, what other care fits the concern and whether further assessment would help. The useful result of a visit is a reasoned next step.
A decision to seek another opinion can begin with the same health concern and the records of what was already discussed.
Page notes
[A] FDA’s BPC-157 review: approval and unresolved questions
[B] FDA explanation of compounded medicines
[C] FDA record of withdrawn ingredient requests
[D] Medical-board guidance on online assessments